Niu, Y., & Zhu, S. (2016). AB187. Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality. Transl Androl Urol.
Style de citation ChicagoNiu, Yuanjie, et Shimiao Zhu. "AB187. Androgen Deprivation Therapy for Prostate Cancer Is Associated With Cardiovascular Morbidity and Mortality." Transl Androl Urol 2016.
Style de citation MLANiu, Yuanjie, et Shimiao Zhu. "AB187. Androgen Deprivation Therapy for Prostate Cancer Is Associated With Cardiovascular Morbidity and Mortality." Transl Androl Urol 2016.
Attention : ces citations peuvent ne pas être correctes à 100%.